This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Martin Olbrich, PhD
Head of Process Chemistry 3 at F Hoffmann-La Roche Ltd.
Speaker

Profile

Martin Olbrich is a Section Lead in Process Chemistry at F. Hoffmann-La Roche.
In this role, he leads a team focused on the development and optimization of manufacturing processes for synthetic molecules, including oligonucleotides and peptides. He has extensive experience in chemical project leadership, coordinating drug substance activities for late-stage oligonucleotide development. He is a member of the European Pharma Oligonucleotide Consortium Steering Committee and contributes to several EPOC topic groups. In addition, he spearheads sustainability initiatives as the Roche Green Chemistry Team Lead

Agenda Sessions

  • Data-Driven Oligonucleotide Development: Integrating Process, Synthesis, and Analytical Insights

    11:00
  • Panel Discussion

    11:15